M. Worthington

669 total citations
15 papers, 541 citations indexed

About

M. Worthington is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Worthington has authored 15 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Worthington's work include Estrogen and related hormone effects (4 papers), Hormonal and reproductive studies (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). M. Worthington is often cited by papers focused on Estrogen and related hormone effects (4 papers), Hormonal and reproductive studies (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). M. Worthington collaborates with scholars based in United Kingdom and United States. M. Worthington's co-authors include David Crook, John C. Stevenson, Ian F. Godsland, C. Walton, Belinda Lees, V. Wynn, K.F. Gangar, Michael P. Cust, Timothy Hillard and Malcolm I. Whitehead and has published in prestigious journals such as The American Journal of Medicine, The Journal of Infectious Diseases and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

M. Worthington

15 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Worthington United Kingdom 12 285 170 128 89 89 15 541
José Luis González‐Sánchez Spain 16 247 0.9× 172 1.0× 90 0.7× 151 1.7× 260 2.9× 24 793
Ruth McManus Canada 10 194 0.7× 85 0.5× 158 1.2× 28 0.3× 99 1.1× 22 648
Debarti Ray India 11 189 0.7× 72 0.4× 59 0.5× 32 0.4× 97 1.1× 13 764
Ronit Koren Israel 14 266 0.9× 70 0.4× 41 0.3× 43 0.5× 128 1.4× 45 545
M. Culliton Ireland 13 214 0.8× 44 0.3× 170 1.3× 33 0.4× 49 0.6× 29 672
W.N. Spellacy United States 13 191 0.7× 89 0.5× 141 1.1× 14 0.2× 41 0.5× 30 552
Mithun Das India 13 187 0.7× 95 0.6× 91 0.7× 81 0.9× 95 1.1× 36 453
MAYUKO H. YAMADA Japan 12 148 0.5× 35 0.2× 87 0.7× 94 1.1× 96 1.1× 40 413
Daad H. Akbar Saudi Arabia 15 333 1.2× 80 0.5× 36 0.3× 53 0.6× 204 2.3× 42 619
Leo Mäkäräinen Finland 14 49 0.2× 60 0.4× 321 2.5× 25 0.3× 26 0.3× 22 653

Countries citing papers authored by M. Worthington

Since Specialization
Citations

This map shows the geographic impact of M. Worthington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Worthington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Worthington more than expected).

Fields of papers citing papers by M. Worthington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Worthington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Worthington. The network helps show where M. Worthington may publish in the future.

Co-authorship network of co-authors of M. Worthington

This figure shows the co-authorship network connecting the top 25 collaborators of M. Worthington. A scholar is included among the top collaborators of M. Worthington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Worthington. M. Worthington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Leyva, Francisco, Ian F. Godsland, M. Worthington, C. Walton, & John C. Stevenson. (1998). Factors of the Metabolic Syndrome. Arteriosclerosis Thrombosis and Vascular Biology. 18(2). 208–214. 52 indexed citations
2.
Godsland, Ian F., Francisco Leyva, C. Walton, M. Worthington, & John C. Stevenson. (1998). Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes risk in the first follow‐up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC‐1). Journal of Internal Medicine. 243(7). 33–41. 9 indexed citations
3.
Walton, C., Belinda Lees, David Crook, et al.. (1995). Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. The American Journal of Medicine. 99(5). 459–464. 141 indexed citations
4.
Marsh, M. S., et al.. (1994). Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.. PubMed. 83(1). 19–23. 30 indexed citations
5.
Worthington, M., L. M. Irvine, David Crook, et al.. (1993). A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis. Fertility and Sterility. 59(3). 522–526. 16 indexed citations
6.
Godsland, IF, David Crook, M. Worthington, et al.. (1993). Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Contraception. 48(3). 217–227. 18 indexed citations
7.
Crook, David, Ian F. Godsland, M. Worthington, et al.. (1993). A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. American Journal of Obstetrics and Gynecology. 169(5). 1183–1189. 36 indexed citations
8.
Crook, David, Michael P. Cust, K.F. Gangar, et al.. (1992). Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. American Journal of Obstetrics and Gynecology. 166(3). 950–955. 156 indexed citations
9.
Crook, David, et al.. (1992). Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in Type IIa hypercholesterolemia. Cardiovascular Drugs and Therapy. 6(6). 633–639. 6 indexed citations
10.
Crook, David, MP Cust, M. Worthington, et al.. (1992). Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. International Journal of Gynecology & Obstetrics. 39(3). 254–254. 5 indexed citations
11.
Worthington, M., et al.. (1983). Further comparisons of endogenous pyrogens and leukocytic endogenous mediators. Infection and Immunity. 41(1). 6–10. 17 indexed citations
12.
Worthington, M.. (1973). Mechanism of Recovery from Systemic Infection with Vaccinia Virus. III. Effects of Antithymocyte Serum. The Journal of Infectious Diseases. 127(5). 518–524. 13 indexed citations
13.
Worthington, M., Hilton B. Levy, & James Mahmud Rice. (1973). Late Therapy of an Arbovirus Encephalitis in Mice with Interferon and Interferon Stimulators. Experimental Biology and Medicine. 143(3). 638–643. 12 indexed citations
14.
Kumar, Rajesh, M. Worthington, Jeremiah G. Tilles, & Walter H. Abelmann. (1971). Effect of the Interferon Stimulator Polyinosinic-Polycytidylic Acid on Experimental Trypanosoma cruzi Infection1,2. Experimental Biology and Medicine. 137(3). 884–888. 14 indexed citations
15.
Worthington, M., et al.. (1971). Late Therapy with an Interferon Stimulator in an Arbovirus Encephalitis in Mice. Experimental Biology and Medicine. 136(1). 323–327. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026